1. Home
  2. MCY vs SRRK Comparison

MCY vs SRRK Comparison

Compare MCY & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercury General Corporation

MCY

Mercury General Corporation

HOLD

Current Price

$106.15

Market Cap

5.8B

Sector

Finance

ML Signal

HOLD

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$58.37

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCY
SRRK
Founded
1961
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.8B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
MCY
SRRK
Price
$106.15
$58.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
13
Target Price
$100.00
$56.17
AVG Volume (30 Days)
246.8K
997.7K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
1.33%
N/A
EPS Growth
15.62
N/A
EPS
8.20
N/A
Revenue
$5,992,468,000.00
N/A
Revenue This Year
$5.16
N/A
Revenue Next Year
$5.59
$534.24
P/E Ratio
$12.89
N/A
Revenue Growth
9.44
N/A
52 Week Low
$74.29
$27.07
52 Week High
$113.06
$58.49

Technical Indicators

Market Signals
Indicator
MCY
SRRK
Relative Strength Index (RSI) 49.68 65.96
Support Level $84.77 $45.81
Resistance Level $111.99 $58.49
Average True Range (ATR) 2.56 2.50
MACD -0.21 0.72
Stochastic Oscillator 32.96 94.37

Price Performance

Historical Comparison
MCY
SRRK

About MCY Mercury General Corporation

Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The company offers the following types of automobile coverage: collision, property damage, bodily injury (BI), comprehensive, personal injury protection (PIP), underinsured and uninsured motorist, and other hazards. Additionally, it offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages. The company has one reportable business segment, the Property and Casualty business segment.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Share on Social Networks: